Home

Aethlon Medical, Inc. - Common Stock (AEMD)

1.2600
-0.6800 (-35.05%)
NASDAQ · Last Trade: Jun 27th, 12:42 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Detailed Quote

Previous Close1.940
Open1.470
Bid1.260
Ask1.270
Day's Range1.200 - 1.470
52 Week Range0.2375 - 2.875
Volume723,657
Market Cap-
PE Ratio (TTM)-
EPS (TTM)-
Dividend & YieldN/A (N/A)
1 Month Average Volume257,996

Chart

About Aethlon Medical, Inc. - Common Stock (AEMD)

Aethlon Medical is a clinical-stage company focused on the development of innovative therapeutic solutions aimed at addressing unmet medical needs, particularly in the areas of infectious diseases and cancer. The company is primarily known for its work on the Aethlon Hemopurifier, a device designed to selectively remove pathogens and other harmful substances from the blood. Aethlon Medical is dedicated to advancing its technologies through rigorous clinical studies, with the goal of improving patient outcomes and enhancing the effectiveness of current treatment options. Read More

News & Press Releases

Let's uncover which stocks are experiencing notable gaps during today's session.chartmill.com
Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Friday. Let's explore the market movements and identify the stocks with significant gaps.
Via Chartmill · June 27, 2025
Stay updated with the stocks that are on the move in today's pre-market session.chartmill.com
The US market is yet to commence its session on Friday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.
Via Chartmill · June 27, 2025
12 Health Care Stocks Moving In Friday's Pre-Market Sessionbenzinga.com
Via Benzinga · June 27, 2025
Preview: Aethlon Medical's Earningsbenzinga.com
Via Benzinga · June 25, 2025
Earnings Scheduled For February 12, 2025benzinga.com
Via Benzinga · February 12, 2025
Earnings Scheduled For November 13, 2024benzinga.com
Via Benzinga · November 13, 2024
An Overview of Aethlon Medical's Earningsbenzinga.com
Via Benzinga · November 12, 2024
12 Health Care Stocks Moving In Thursday's After-Market Sessionbenzinga.com
Via Benzinga · June 26, 2025
Get insights into the top gainers and losers of Thursday's after-hours session.chartmill.com
After the closing bell on Thursday, let's take a glimpse of the US markets and explore the top gainers and losers in today's after-hours session.
Via Chartmill · June 26, 2025
Earnings Scheduled For June 26, 2025benzinga.com
Via Benzinga · June 26, 2025
12 Health Care Stocks Moving In Wednesday's After-Market Sessionbenzinga.com
Via Benzinga · June 25, 2025
12 Health Care Stocks Moving In Monday's After-Market Sessionbenzinga.com
Via Benzinga · May 19, 2025
12 Health Care Stocks Moving In Tuesday's After-Market Sessionbenzinga.com
Via Benzinga · April 8, 2025
12 Health Care Stocks Moving In Thursday's Pre-Market Sessionbenzinga.com
Via Benzinga · January 2, 2025
Why MicroStrategy Shares Are Trading Higher By Over 5%; Here Are 20 Stocks Moving Premarketbenzinga.com
Shares of MicroStrategy Incorporated (NASDAQ:MSTR) rose sharply in today's pre-market trading.
Via Benzinga · January 2, 2025
12 Health Care Stocks Moving In Friday's Pre-Market Sessionbenzinga.com
Via Benzinga · December 20, 2024
12 Health Care Stocks Moving In Thursday's Pre-Market Sessionbenzinga.com
Via Benzinga · December 19, 2024
US Stocks Higher, Micron Reports Downbeat Salesbenzinga.com
Via Benzinga · December 19, 2024
Why Sangamo Therapeutics Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarketbenzinga.com
Via Benzinga · December 19, 2024
Why Tesla Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarketbenzinga.com
Via Benzinga · November 18, 2024
12 Health Care Stocks Moving In Wednesday's Pre-Market Sessionbenzinga.com
Via Benzinga · October 9, 2024
Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com
By Virtual Investor Conferences · Via GlobeNewswire · September 20, 2024
Immunotherapy Clinical Trials - A New Approach to Treating Cancer
Vancouver, Kelowna, and Delta, British Columbia--(Newsfile Corp. - September 19, 2024) - Investorideas.com, a go-to investing platform, releases the ...
Via Newsfile · September 19, 2024
Innovation Driving Cancer's Solid Tumors Market
Vancouver, Kelowna, and Delta, British Columbia--(Newsfile Corp. - September 17, 2024) - Investorideas.com, a go-to investing platform, releases the...
Via Newsfile · September 17, 2024
Life Sciences Virtual Investor Forum Agenda Announced for September 19th
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com
By Virtual Investor Conferences · Via GlobeNewswire · September 16, 2024